The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?
More from Resources from Summit Global Education bloomberg.com
No comments yet. Be the first to comment!